Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Management of adverse reactions to first-line tuberculosis antibiotics.

Nagarajan S, Whitaker P.

Curr Opin Allergy Clin Immunol. 2018 Aug;18(4):333-341. doi: 10.1097/ACI.0000000000000462.

PMID:
29901473
2.

Advances in hypersensitivity drug reactions.

Blanca M, Whitaker P.

Curr Opin Allergy Clin Immunol. 2018 Aug;18(4):281-283. doi: 10.1097/ACI.0000000000000460. No abstract available.

PMID:
29889139
3.

The impact of three discharge coding methods on the accuracy of diagnostic coding and hospital reimbursement for inpatient medical care.

Tsopra R, Peckham D, Beirne P, Rodger K, Callister M, White H, Jais JP, Ghosh D, Whitaker P, Clifton IJ, Wyatt JC.

Int J Med Inform. 2018 Jul;115:35-42. doi: 10.1016/j.ijmedinf.2018.03.015. Epub 2018 Mar 27.

PMID:
29779718
4.

Intravenous fosfomycin for pulmonary exacerbation of cystic fibrosis: Real life experience of a large adult CF centre.

Spoletini G, Kennedy M, Flint L, Graham T, Etherington C, Shaw N, Whitaker P, Denton M, Clifton I, Peckham D.

Pulm Pharmacol Ther. 2018 Jun;50:82-87. doi: 10.1016/j.pupt.2018.04.007. Epub 2018 Apr 13.

PMID:
29660401
5.

Up-Regulation of T-Cell Activation MicroRNAs in Drug-Specific CD4+ T-Cells from Hypersensitive Patients.

Monroy-Arreola A, Durán-Figueroa NV, Méndez-Flores S, Domínguez-Cherit J, Watkinson J, Badillo-Corona JA, Whitaker P, Naisbitt DJ, Castrejón-Flores JL.

Chem Res Toxicol. 2018 Jun 18;31(6):454-461. doi: 10.1021/acs.chemrestox.7b00330. Epub 2018 May 16.

PMID:
29644860
6.

Correction: Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in Patients.

Meng X, Al-Attar Z, Yaseen FS, Jenkins R, Earnshaw C, Whitaker P, Peckham D, French NS, Naisbitt DJ, Park BK.

J Immunol. 2018 Mar 1;200(5):1952. doi: 10.4049/jimmunol.1800020. Epub 2018 Feb 2. No abstract available.

PMID:
29427419
7.

GMC erasure case: we must improve systems to mitigate inevitable mistakes.

Whitaker P.

BMJ. 2018 Jan 18;360:k183. doi: 10.1136/bmj.k183. No abstract available.

PMID:
29348157
8.

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis.

Sawant A, Spoletini G, Whitaker P, Etherington C, Clifton I, Peckham D.

ERJ Open Res. 2018 Jan 10;4(1). pii: 00111-2017. doi: 10.1183/23120541.00111-2017. eCollection 2018 Jan.

9.

Assessment of Antipiperacillin IgG Binding to Structurally Related Drug Protein Adducts.

Amali MO, Jenkins RE, Meng X, Faulkner L, Whitaker P, Peckham D, Park BK, Naisbitt DJ.

Chem Res Toxicol. 2017 Dec 18;30(12):2097-2099. doi: 10.1021/acs.chemrestox.7b00291. Epub 2017 Nov 22.

PMID:
29148816
10.

Invasive Pulmonary Fungal Infections in Cystic Fibrosis.

Schwarz C, Brandt C, Whitaker P, Sutharsan S, Skopnik H, Gartner S, Smazny C, Röhmel JF.

Mycopathologia. 2018 Feb;183(1):33-43. doi: 10.1007/s11046-017-0199-4. Epub 2017 Sep 1.

PMID:
28864921
11.

Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in Patients.

Meng X, Al-Attar Z, Yaseen FS, Jenkins R, Earnshaw C, Whitaker P, Peckham D, French NS, Naisbitt DJ, Park BK.

J Immunol. 2017 Jun 1;198(11):4217-4227. doi: 10.4049/jimmunol.1700209. Epub 2017 Apr 24. Erratum in: J Immunol. 2018 Feb 2;:.

12.

β-Lactam hypersensitivity involves expansion of circulating and skin-resident TH22 cells.

Sullivan A, Wang E, Farrell J, Whitaker P, Faulkner L, Peckham D, Park BK, Naisbitt DJ.

J Allergy Clin Immunol. 2018 Jan;141(1):235-249.e8. doi: 10.1016/j.jaci.2017.01.020. Epub 2017 Feb 20.

PMID:
28219704
13.

Detection of Drug-Responsive T-Lymphocytes in a Case of Fatal Antituberculosis Drug-Related Liver Injury.

Usui T, Whitaker P, Meng X, Watson J, Antoine DJ, French NS, Park BK, Naisbitt DJ.

Chem Res Toxicol. 2016 Nov 21;29(11):1793-1795. Epub 2016 Nov 9.

PMID:
27933861
14.

Detection of drug-responsive B lymphocytes and antidrug IgG in patients with β-lactam hypersensitivity.

Amali MO, Sullivan A, Jenkins RE, Farrell J, Meng X, Faulkner L, Whitaker P, Peckham D, Park BK, Naisbitt DJ.

Allergy. 2017 Jun;72(6):896-907. doi: 10.1111/all.13087. Epub 2016 Dec 8.

PMID:
27861994
15.

From the Cover: Characterization of Isoniazid-Specific T-Cell Clones in Patients with anti-Tuberculosis Drug-Related Liver and Skin Injury.

Usui T, Meng X, Saide K, Farrell J, Thomson P, Whitaker P, Watson J, French NS, Kevin Park B, Naisbitt DJ.

Toxicol Sci. 2017 Feb;155(2):420-431. doi: 10.1093/toxsci/kfw218. Epub 2016 Nov 1.

PMID:
27803386
16.

Survival of Mycobacterium abscessus isolated from people with cystic fibrosis in artificially generated aerosols.

Fletcher LA, Chen Y, Whitaker P, Denton M, Peckham DG, Clifton IJ.

Eur Respir J. 2016 Dec;48(6):1789-1791. doi: 10.1183/13993003.00849-2016. Epub 2016 Sep 22. No abstract available.

17.

Amoxicillin and Clavulanate Form Chemically and Immunologically Distinct Multiple Haptenic Structures in Patients.

Meng X, Earnshaw CJ, Tailor A, Jenkins RE, Waddington JC, Whitaker P, French NS, Naisbitt DJ, Park BK.

Chem Res Toxicol. 2016 Oct 17;29(10):1762-1772. Epub 2016 Sep 21.

PMID:
27603302
18.

GPs are much more than gatekeepers.

Whitaker P; GP and author.

BMJ. 2016 May 18;353:i2751. doi: 10.1136/bmj.i2751. No abstract available.

PMID:
27193762
19.

In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper.

Mayorga C, Celik G, Rouzaire P, Whitaker P, Bonadonna P, Rodrigues-Cernadas J, Vultaggio A, Brockow K, Caubet JC, Makowska J, Nakonechna A, Romano A, Montañez MI, Laguna JJ, Zanoni G, Gueant JL, Oude Elberink H, Fernandez J, Viel S, Demoly P, Torres MJ; In vitro tests for Drug Allergy Task Force of EAACI Drug Interest Group.

Allergy. 2016 Aug;71(8):1103-34. doi: 10.1111/all.12886. Epub 2016 May 25.

PMID:
26991315
20.

Occupational allergy to pharmaceutical products.

Whitaker P.

Curr Opin Allergy Clin Immunol. 2016 Apr;16(2):101-6. doi: 10.1097/ACI.0000000000000248. Review.

PMID:
26871933
21.

Ultrasound and magnetic resonance imaging assessment of joint disease in symptomatic patients with cystic fibrosis arthropathy.

Fitch G, Williams K, Freeston JE, Dass S, Grainger A, Hodgson R, Horton L, Whitaker P, Peckham D.

J Cyst Fibros. 2016 Jul;15(4):e35-40. doi: 10.1016/j.jcf.2015.12.022. Epub 2016 Jan 20.

22.

Pathogenicity of individual rhinovirus species during exacerbations of cystic fibrosis.

Shah A, Connelly M, Whitaker P, McIntyre C, Etherington C, Denton M, Hale A, Harvala H, Simmonds P, Peckham DG.

Eur Respir J. 2015 Jun;45(6):1748-51. doi: 10.1183/09031936.00229114. No abstract available.

23.

HLA-DQ allele-restricted activation of nitroso sulfamethoxazole-specific CD4-positive T lymphocytes from patients with cystic fibrosis.

Ogese MO, Saide K, Faulkner L, Whitaker P, Peckham D, Alfirevic A, Baker DM, Sette A, Pirmohamed M, Park BK, Naisbitt DJ.

Clin Exp Allergy. 2015 Aug;45(8):1305-16. doi: 10.1111/cea.12546.

PMID:
25851465
24.

Characterization of Peroxidases Expressed in Human Antigen Presenting Cells and Analysis of the Covalent Binding of Nitroso Sulfamethoxazole to Myeloperoxidase.

Ogese MO, Jenkins RE, Maggs JL, Meng X, Whitaker P, Peckham D, Faulkner L, Park BK, Naisbitt DJ.

Chem Res Toxicol. 2015 Jan 20;28(1):144-54. doi: 10.1021/tx500458k. Epub 2015 Jan 7.

PMID:
25531135
25.

Research in progress-electronic patient records: a new era.

Peckham D, Whitaker P, White H.

Thorax. 2015 May;70(5):473-5. doi: 10.1136/thoraxjnl-2014-206573. Epub 2014 Dec 10. Review.

PMID:
25504824
26.

Auto-oxidation of Isoniazid Leads to Isonicotinic-Lysine Adducts on Human Serum Albumin.

Meng X, Maggs JL, Usui T, Whitaker P, French NS, Naisbitt DJ, Park BK.

Chem Res Toxicol. 2015 Jan 20;28(1):51-8. doi: 10.1021/tx500285k. Epub 2014 Dec 9.

PMID:
25489718
27.

Occupational anaphylaxis--an EAACI task force consensus statement.

Siracusa A, Folletti I, Gerth van Wijk R, Jeebhay MF, Moscato G, Quirce S, Raulf M, Ruëff F, Walusiak-Skorupa J, Whitaker P, Tarlo SM.

Allergy. 2015 Feb;70(2):141-52. doi: 10.1111/all.12541. Review.

PMID:
25369880
28.

Lumenless pacing leads: performance and extraction in pediatrics and congenital heart disease.

Garnreiter J, Whitaker P, Pilcher T, Etheridge S, Saarel E.

Pacing Clin Electrophysiol. 2015 Jan;38(1):42-7. doi: 10.1111/pace.12508. Epub 2014 Sep 16.

PMID:
25224253
29.

Reply to Professor Taylor.

Peckham D, Whitaker P.

J Cyst Fibros. 2014 Jul;13(4):486-7. doi: 10.1016/j.jcf.2014.03.001. Epub 2014 Apr 18. No abstract available.

30.

The development and deployment of integrated electronic care records in a regional adult and paediatric cystic fibrosis unit.

Peckham D, Etherington C, White H, Mehta A, Shaw N, Morton A, Pollard K, Lee T, Brownlee K, Taylor J, Whitaker P, Conway S.

J Cyst Fibros. 2014 Dec;13(6):681-6. doi: 10.1016/j.jcf.2014.03.002. Epub 2014 Mar 23.

31.

Negative regulation by PD-L1 during drug-specific priming of IL-22-secreting T cells and the influence of PD-1 on effector T cell function.

Gibson A, Ogese M, Sullivan A, Wang E, Saide K, Whitaker P, Peckham D, Faulkner L, Park BK, Naisbitt DJ.

J Immunol. 2014 Mar 15;192(6):2611-2621. doi: 10.4049/jimmunol.1302720. Epub 2014 Feb 7.

32.

The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation.

Etherington C, Naseer R, Conway SP, Whitaker P, Denton M, Peckham DG.

J Cyst Fibros. 2014 Jan;13(1):49-55. doi: 10.1016/j.jcf.2013.06.004. Epub 2013 Jul 23.

33.

Drug induced complications; can we do more?

Peckham D, Whitaker P.

J Cyst Fibros. 2013 Dec;12(6):547-58. doi: 10.1016/j.jcf.2013.04.014. Epub 2013 Jun 13. Review.

34.

Desensitization in delayed drug hypersensitivity reactions -- an EAACI position paper of the Drug Allergy Interest Group.

Scherer K, Brockow K, Aberer W, Gooi JH, Demoly P, Romano A, Schnyder B, Whitaker P, Cernadas JS, Bircher AJ; ENDA, the European Network on Drug Allergy and the EAACI Drug Allergy Interest Group.

Allergy. 2013 Jul;68(7):844-52. doi: 10.1111/all.12161. Epub 2013 Jun 7. Review.

PMID:
23745779
35.

β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis.

Jenkins RE, Yaseen FS, Monshi MM, Whitaker P, Meng X, Farrell J, Hamlett J, Sanderson JP, El-Ghaiesh S, Peckham D, Pirmohamed M, Park BK, Naisbitt DJ.

Chem Res Toxicol. 2013 Jun 17;26(6):963-75. doi: 10.1021/tx400124m. Epub 2013 May 23.

PMID:
23668298
36.

Nebuliser systems for drug delivery in cystic fibrosis.

Daniels T, Mills N, Whitaker P.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD007639. doi: 10.1002/14651858.CD007639.pub2. Review.

PMID:
23633344
37.

Nebuliser systems for drug delivery in cystic fibrosis.

Daniels T, Mills N, Whitaker P.

Paediatr Respir Rev. 2013 Jun;14(2):98-9. doi: 10.1016/j.prrv.2013.03.004. Epub 2013 Apr 10. Review. No abstract available.

PMID:
23583049
38.

Nonimmediate β-lactam reactions in patients with cystic fibrosis.

Whitaker P, Naisbitt D, Peckham D.

Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):369-75. doi: 10.1097/ACI.0b013e328355b849. Review.

PMID:
22729028
39.

Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Greally P, Whitaker P, Peckham D.

Curr Med Res Opin. 2012 Jun;28(6):1059-67. doi: 10.1185/03007995.2012.674500. Epub 2012 May 10. Review.

PMID:
22401602
40.

Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis.

El-Ghaiesh S, Monshi MM, Whitaker P, Jenkins R, Meng X, Farrell J, Elsheikh A, Peckham D, French N, Pirmohamed M, Park BK, Naisbitt DJ.

J Pharmacol Exp Ther. 2012 Jun;341(3):597-610. doi: 10.1124/jpet.111.190900. Epub 2012 Feb 27.

41.

The use of nebulised aztreonam lysine (AZLI) in aztreonam hypersensitive patients.

Whitaker P, Etherington C, Williams K, Conway S, Peckham D.

J Cyst Fibros. 2012 Jul;11(4):353. doi: 10.1016/j.jcf.2012.01.007. Epub 2012 Feb 16. No abstract available.

42.

The unique effects of environmental strategies in health promotion campaigns: a review.

Randolph KA, Whitaker P, Arellano A.

Eval Program Plann. 2012 Aug;35(3):344-53. doi: 10.1016/j.evalprogplan.2011.12.004. Epub 2011 Dec 29. Review.

PMID:
22265758
43.

The 10th anniversary of the Junior Members and Affiliates of the European Academy of Allergy and Clinical Immunology.

Skevaki CL, Maggina P, Santos AF, Rodrigues-Alves R, Antolin-Amerigo D, Borrego LM, Bretschneider I, Butiene I, Couto M, Fassio F, Gardner J, Xatzipsalti M, Hovhannisyan L, Hox V, Makrinioti H, O Neil SE, Pala G, Rudenko M, Santucci A, Seys S, Sokolowska M, Whitaker P, Heffler E.

Pediatr Allergy Immunol. 2011 Dec;22(8):754-7. doi: 10.1111/j.1399-3038.2011.01238.x.

PMID:
22122787
44.

Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.

Clifton IJ, Whitaker P, Metcalfe R, Phillip M, Shaw N, Conway SP, Peckham DG.

J Antimicrob Chemother. 2011 Oct;66(10):2438-40. doi: 10.1093/jac/dkr300. Epub 2011 Jul 25. No abstract available.

PMID:
21791443
45.

Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis.

Whitaker P, Meng X, Lavergne SN, El-Ghaiesh S, Monshi M, Earnshaw C, Peckham D, Gooi J, Conway S, Pirmohamed M, Jenkins RE, Naisbitt DJ, Park BK.

J Immunol. 2011 Jul 1;187(1):200-11. doi: 10.4049/jimmunol.1100647. Epub 2011 May 23.

46.

Rapid desensitization for non-immediate reactions in patients with cystic fibrosis.

Whitaker P, Shaw N, Gooi J, Etherington C, Conway S, Peckham D.

J Cyst Fibros. 2011 Jul;10(4):282-5. doi: 10.1016/j.jcf.2011.02.002. Epub 2011 Mar 9.

47.

Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosis.

Elsheikh A, Castrejon L, Lavergne SN, Whitaker P, Monshi M, Callan H, El-Ghaiesh S, Farrell J, Pichler WJ, Peckham D, Park BK, Naisbitt DJ.

J Allergy Clin Immunol. 2011 Jun;127(6):1543-51.e3. doi: 10.1016/j.jaci.2010.12.1119. Epub 2011 Feb 26.

PMID:
21354601
48.

Sequential bronchoscopy in the management of lobar atelectasis secondary to allergic bronchopulmonary aspergillosis.

Whitaker P, Brownlee K, Lee T, Conway S, Etherington C, Peckham D.

J Bronchology Interv Pulmonol. 2011 Jan;18(1):57-60. doi: 10.1097/LBR.0b013e318206ea63.

PMID:
23169021
49.

Drug metabolite-specific lymphocyte responses in sulfamethoxazole allergic patients with cystic fibrosis.

Lavergne SN, Whitaker P, Peckham D, Conway S, Park BK, Naisbitt DJ.

Chem Res Toxicol. 2010 Jun 21;23(6):1009-11. doi: 10.1021/tx100151v.

PMID:
20481640
50.

Connecting information to improve health.

Hammond WE, Bailey C, Boucher P, Spohr M, Whitaker P.

Health Aff (Millwood). 2010 Feb;29(2):284-8. doi: 10.1377/hlthaff.2009.0903.

PMID:
20348075

Supplemental Content

Loading ...
Support Center